ABBV - AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) Meeting
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.